GE Medical Systems has signed a clinical trial agreement with the National Cancer Institute’s Cancer Imaging Program. The multisite clinical trials will evaluate 18F-fluorothymidine (FLT) as an agent for PET studies.
Breast imaging developer Hologic and computer-aided detection (CAD) provider Confirma have partnered to distribute Confirma’s MRI CADstream system to the mammography market.
Interventional device developer Boston Scientific of Natick, MA, reports that the Circulatory System Devices Panel has unanimously recommended U. S. Food and Drug Administration approval for the firm’s Taxus Express2 paclitaxel-eluting coronary stent system